Novo Nordisk
NVO
564 hedge funds and large institutions have $8.88B invested in Novo Nordisk in 2019 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 179 increasing their positions, 211 reducing their positions, and 46 closing their positions.
68% more call options, than puts
Call options by funds: $79.2M | Put options by funds: $47.1M
20% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 46
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
1% more funds holding
Funds holding: 559 → 564 (+5)
0% less capital invested
Capital invested by funds: $8.89B → $8.88B (-$10.8M)
0.2% less ownership
Funds ownership: 18.73% → 18.53% (-0.2%)
15% less repeat investments, than reductions
Existing positions increased: 179 | Existing positions reduced: 211
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$115M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$37.6M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$35.4M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$33.2M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$26.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$83.1M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$49.7M |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$49.6M |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$37.4M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$36.6M |
NVO Hedge Fund Activity: Q3 2019 in Review
564 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2019, worth a combined $8.88B — down 0.12% from $8.89B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new NVO positions and 46 closed out — a net gain of 9 holders — while 179 added to existing stakes and 211 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $115M. The largest seller was BlackRock, cutting an estimated $83.1M.
- 564 institutional investors held Novo Nordisk (NVO) as of Q3 2019, up from 559 in Q2 2019.
- Funds reported $8.88B of Novo Nordisk stock for Q3 2019, down 0.12% quarter-over-quarter.
- 55 funds opened new Novo Nordisk positions in Q3 2019 and 46 closed out, a net change of +9 holders.
- The largest Novo Nordisk buyer in Q3 2019 was Renaissance Technologies, an estimated $115M added.
- The largest Novo Nordisk seller in Q3 2019 was BlackRock, an estimated $83.1M sold.
Based on aggregated 13F filings for Q3 2019.